JamesMatthewKoomeyMD

Oncology • Plymouth, MA

Physician

Join to view full profile

Dr. Koomey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Koomey's full profile

Already have an account?

Office
275 Sandwich St
C/O Cathy Grey
Plymouth, MA 02360
Phone+1 508-830-2390

Fax+1 508-830-2399
Is this information wrong?

Education & Training

Boston University Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Boston University Medical CenterResidency, Internal Medicine, 1995 - 1998
Boston University School of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 1998 - 2025

Clinical Trials

Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer Start of enrollment: 2006 Sep 26
Active, not recruiting
Phase 3
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Start of enrollment: 2010 Oct 25
Completed
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Recombinant human tumor necrosis factor alpha promotes adherence of Staphylococcus aureus to cultured human endothelial cells.
Cheung, A. L., Koomey, J. M., Lee, S., Jaffe, E. A., Fischetti, V. A.> ;Infect Immun. 1991 Oct
Genetic diversity among the T-protein genes of group A streptococci.
Jones, K. F., Schneewind, O., Koomey, J. M., Fischetti, V. A.> ;Mol Microbiol. 1991 Dec
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) distinct from agr.
Cheung, A. L., Koomey, J. M., Butler, C. A., Projan, S. J., Fischetti, V. A.> ;Proc Natl Acad Sci U S A. 1992 Jul 15

Hospital Affiliations

Beth Israel Deaconess Hospital-PlymouthPlymouth, Massachusetts